Scholarly Index
Christophe Guignabert
Inserm; 14,294 total citations; 287 total publications; best world rank #23
Inserm
14,294Total citations
287Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pulmonary Hypertension Research and Treatments | Lifetime | 117 | FR 13 | 99.19 |
| Cardiovascular Issues in Pregnancy | Lifetime | 326 | FR 16 | 97.24 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 585 | FR 39 | 97.14 |
| Vascular Anomalies and Treatments | Lifetime | 228 | FR 31 | 94.69 |
| Macrophage Migration Inhibitory Factor | Lifetime | 468 | FR 6 | 88.03 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 681 | FR 43 | 88.88 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 23 | FR 5 | 99.07 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 234 | FR 14 | 95.88 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 861 | FR 30 | 74.82 |
| Vascular Anomalies and Treatments | 2021-2025 | 232 | FR 36 | 74.01 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 455 | FR 5 | 67.88 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 388 | FR 19 | 54.91 |